Literature DB >> 10534739

Estimating the time of HTLV-I infection following mother-to-child transmission in a breast-feeding population in Jamaica.

A Furnia1, R Lal, E Maloney, S Wiktor, E Pate, D Rudolph, D Waters, W Blattner, A Manns.   

Abstract

Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) is primarily due to prolonged breast-feeding (>6 months) in the postnatal period. Most infant infections are not identifiable until 12 to 18 months of age by available whole virus Western blot serologic tests because of their inability to distinguish passively transferred maternal antibody from infant antibody. We investigated two methods to assess more accurately the time of infant infection. In prospectively collected serial biospecimens, HTLV-I-specific immunoglobulin (Ig) isotypes of IgM and IgA were determined by Western blot and HTLV-I proviral DNA was detected by polymerase chain reaction (PCR). IgA and IgG reactivity was assessed in periodic serum samples from 16 HTLV-I-seropositive children while IgM reactivity was assessed in 9 of the 16 children. Approximately three to five samples were tested for each child. IgG reactivity was observed in 100% of children at 24 months of age and 73% of children at 6-12 months of age; however, this could represent maternal and not infant antibody. Both IgA and IgM reactivity were insensitive indicators of infection, with only 50% of children showing reactivity at 24 months of age. PCR testing was performed in biospecimens obtained from 11 of these children. An estimated median time of infection of 11.9 months was determined by PCR, which was similar to the median time to infection determined by whole virus Western blot (12.4 months; P = 0.72). PCR tests support a median time to infection that is similar to that estimated by whole virus Western blot. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534739     DOI: 10.1002/(sici)1096-9071(199912)59:4<541::aid-jmv19>3.0.co;2-s

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

Review 1.  [Vertical transmission of HTLV-1 in Peru].

Authors:  Jorge Alarcón Villaverde; Franco Romaní Romaní; Silvia Montano Torres; Joseph R Zunt
Journal:  Rev Peru Med Exp Salud Publica       Date:  2011-03

Review 2.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

3.  Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results.

Authors:  Francesca Vitone; Davide Gibellini; Pasqua Schiavone; Antonietta D'Antuono; Lorenzo Gianni; Isabella Bon; Maria Carla Re
Journal:  BMC Infect Dis       Date:  2006-03-02       Impact factor: 3.090

Review 4.  Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).

Authors:  Sanaz Ahmadi Ghezeldasht; Abbas Shirdel; Mohammad Ali Assarehzadegan; Tahereh Hassannia; Hosian Rahimi; Rahele Miri; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

5.  Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-1-infected offspring.

Authors:  Arthur M Paiva; Tatiane Assone; Michel E J Haziot; Jerusa Smid; Luiz Augusto M Fonseca; Olinda do Carmo Luiz; Augusto Cesar Penalva de Oliveira; Jorge Casseb
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

Review 6.  Breast milk and infection.

Authors:  Robert M Lawrence; Ruth A Lawrence
Journal:  Clin Perinatol       Date:  2004-09       Impact factor: 3.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.